How to leverage non-dilutive funding
May 27, 2025
Learn how to leverage non-dilutive funding by taking advantage of SR&ED and government grants to unlock crucial financial support.
Learn how to leverage non-dilutive funding by taking advantage of SR&ED and government grants to unlock crucial financial support.
Discover how Afynia Laboratories secured a $5 million seed round to commercialize its microRNA panel test for endometriosis.
Discover how Innovation Factory’s HEALTHI program helped generate $7.5 million in commercialization funding.
Lactiga leads the way in antibody therapies with a significant grant from NIH to enhance treatment for immune deficiencies.
This funding will enable Vessl to accelerate the development of its cutting-edge prosthetic devices, advancing the company’s mission to empower amputees to live fuller, more independent lives.
Verv Technologies is advancing the development of their medical device for in-home blood tests with funding from the Sudbury Catalyst Fund.
Enhanced Medical Nutrition raises $5M Series A to expand ENROUTE®, a groundbreaking nutrition program improving surgical outcomes through innovation and care.
13 innovative companies have received funding through Innovation Factory, in partnership with Boundless Accelerator, through Cohort 3 of the Government of Canada-supported i.d.e.a. Fund.
HEALWELL has acquired a majority controlling interest in Mutuo Health Solutions, a Toronto-based medical artificial intelligence company focused on developing predictive clinical AI technology.
As the winning pitch, Leynek Medical was awarded a $25,000 investment to support the next phase of their product adoption to help get their solution into hospitals and clinics.
Learn how to leverage non-dilutive funding by taking advantage of SR&ED and government grants to unlock crucial financial support.
Discover how Afynia Laboratories secured a $5 million seed round to commercialize its microRNA panel test for endometriosis.
Discover how Innovation Factory’s HEALTHI program helped generate $7.5 million in commercialization funding.
Lactiga leads the way in antibody therapies with a significant grant from NIH to enhance treatment for immune deficiencies.
This funding will enable Vessl to accelerate the development of its cutting-edge prosthetic devices, advancing the company’s mission to empower amputees to live fuller, more independent lives.
Verv Technologies is advancing the development of their medical device for in-home blood tests with funding from the Sudbury Catalyst Fund.
Enhanced Medical Nutrition raises $5M Series A to expand ENROUTE®, a groundbreaking nutrition program improving surgical outcomes through innovation and care.
13 innovative companies have received funding through Innovation Factory, in partnership with Boundless Accelerator, through Cohort 3 of the Government of Canada-supported i.d.e.a. Fund.
HEALWELL has acquired a majority controlling interest in Mutuo Health Solutions, a Toronto-based medical artificial intelligence company focused on developing predictive clinical AI technology.
As the winning pitch, Leynek Medical was awarded a $25,000 investment to support the next phase of their product adoption to help get their solution into hospitals and clinics.
Get the latest updates delivered straight to your inbox! Stay notified about companies on the grow, the latest tech trends, funding news and opportunities, industry insights, upcoming events and more from across Hamilton and Halton’s innovation ecosystem.
